Drug detox for Coral Springs — substance-specific protocols, not one-size-fits-all.

RECO Island runs a small-census, physician-led medical detox 35 minutes from Coral Springs via the Sawgrass Expressway and I-95, with direct in-house transition to residential — no waitlists and no third-party handoffs. Substance-specific protocols — COWS-guided buprenorphine induction for opioids, slow long-half-life tapers for benzodiazepines, supportive management with early mood-disorder screening for stimulants — replace the one-size-fits-all approach common to regional detox admissions. MAT continues through residential and PHP/IOP, and medical comorbidity is worked up on day one rather than deferred to outpatient primary care after discharge.

Coral Springs sits 25 miles inland from RECO Island’s Delray Beach campus — a 35-minute drive east on the Sawgrass Expressway to I-95, then south along the coastline that has anchored South Florida’s recovery community for decades. For families in Eagle Trace, Hidden Hammocks, Parkland Isles, Cypress Run, and Heron Bay, the practical question in medical drug detox is rarely about proximity. It is whether the withdrawal protocol matches the substance, and whether the handoff into residential and MAT is engineered in or improvised at discharge.

Substance-specific withdrawal protocols

Opioid, benzodiazepine, and stimulant withdrawal are three clinically distinct syndromes that require three different management strategies. Opioid withdrawal — piloerection, myalgia, GI distress, dysphoria, insomnia, craving — is intensely uncomfortable but rarely medically dangerous in isolation. RECO Island’s opioid detox uses COWS-guided buprenorphine induction: waiting for a COWS score in the moderate range before the first dose to avoid precipitated withdrawal, titrating to symptom relief across the first 24 to 48 hours, and stabilizing on a maintenance dose that carries into residential and outpatient continuation. Methadone induction is used selectively for clients with prior methadone stabilization or specific clinical indications.

Benzodiazepine withdrawal is a fundamentally different problem. Uncontrolled cessation can produce seizures, delirium, and autonomic instability — the syndrome resembles alcohol withdrawal in mechanism and severity. RECO Island’s benzodiazepine detox converts short half-life agents such as alprazolam and lorazepam to a long half-life agent — typically clonazepam or diazepam — and tapers over weeks rather than days. Compressing a benzodiazepine taper to fit an insurance day limit is not clinically defensible, and it is not the approach used here.

Stimulant withdrawal — cocaine, methamphetamine — presents primarily as depression, anhedonia, hypersomnia, and intense craving. There is no FDA-approved medication protocol, but the clinical need is real: nutritional restoration, sleep normalization, cardiovascular evaluation, and early screening for the mood disorders that frequently emerge once stimulant use stops masking underlying pathology. Running a single generic protocol across all substances is bad medicine.

Polysubstance detox and the sequencing decision

Concurrent use of alcohol, benzodiazepines, and opioids — often with a stimulant layered on top — is now the more frequent presentation than any single-substance case. Polysubstance detox requires deliberate sequencing rather than parallel management of independent protocols. The general clinical principle is to prioritize the withdrawal syndromes that are life-threatening first: alcohol and benzodiazepine withdrawal are managed with the appropriate long-acting taper, tracked with CIWA-Ar for alcohol and structured clinical assessment for benzodiazepines. Opioid MAT is initiated concurrently once buprenorphine induction is safe. Stimulant withdrawal is addressed supportively in parallel.

Every polysubstance case at RECO Island receives an individualized detox plan documented before the first dose — which substances, in what quantities, over what duration, with what psychiatric and medical comorbidity, and against what current prescription list. The plan is updated daily as vitals, symptom scales, and the clinical picture evolve. Boilerplate protocols fail polysubstance cases in predictable ways, which is why they are not used.

Medical comorbidity is the norm, not the exception

Chronic substance use produces a predictable pattern of medical comorbidity that most detox admissions bring through the door. Injection opioid use carries associations with hepatitis C, endocarditis history, and recurrent injection-site infections. Stimulant use produces cardiovascular sequelae — hypertension, cardiomyopathy, arrhythmia risk — that must be documented before pharmacologic decisions are finalized. Long-standing alcohol use produces hepatic dysfunction, thiamine depletion, and often undiagnosed pancreatitis. Across substances, malnutrition, untreated dental disease, chronic pain that was self-medicated, undiagnosed diabetes, hypertension, and sleep-disordered breathing are common findings on admission workup.

RECO Island’s admission evaluation — history and physical, laboratory panel, ECG when indicated, hepatitis serologies, and formal medication reconciliation — catches the comorbidity that has often been the reason substance use continued in the first place. Chronic pain that was managed with opioids does not disappear when opioids are removed; it needs a documented non-opioid pain plan. Untreated depression that fueled stimulant use needs psychiatric evaluation and, where indicated, initiation of sertraline, bupropion, or another appropriate agent during residential rather than deferred to outpatient six weeks after discharge. Detox is often the first serious medical contact in years, and it is treated accordingly.

The handoff into residential and MAT continuation

Detox is the beginning of treatment, not the treatment itself. Standalone detox — completed without residential continuation and without medication-assisted treatment — carries a relapse rate that clinical literature documents as near-universal for opioid use disorder in particular. RECO Island’s model is engineered around this fact: detox transitions directly to residential on the same campus, with no discharge-and-refer gap and no third-party handoff during what is the highest-risk window in the recovery trajectory.

MAT is initiated during detox where clinically indicated — buprenorphine for opioid use disorder, naltrexone for alcohol use disorder or for OUD after an appropriate opioid-free window — and continues through residential, PHP, and IOP. At discharge, MAT is handed off to a community prescriber with an intake appointment already booked, not a phone number and a hope. Evidence-based therapies — CBT, DBT, motivational interviewing, contingency management, and trauma-focused work including EMDR — run through the residential and outpatient phases. Medication is the floor; therapy is the structure built on it.

What to expect on the first day of admission

Admission begins with a phone assessment: insurance verification, substance use history, psychiatric and medical history, current medications, and a clinical screen for imminent safety concerns. Assessment scales including PHQ-9 for depression, GAD-7 for anxiety, COWS or CIWA-Ar as indicated, and the six ASAM Criteria dimensions determine the appropriate level of care. For most Coral Springs and Parkland families, admission happens within 24 hours of the initial call.

On arrival at the Delray Beach campus, medical evaluation, psychiatric evaluation, and nursing intake occur in the first hours. The detox plan — substances involved, medications, monitoring schedule, taper timeline — is documented before the first dose is administered. Family communication protocols are established early: what will be shared, with whom, and on what cadence, all inside HIPAA and 42 CFR Part 2 authorizations. Small census means clinicians know each client by clinical picture rather than by room number.

Insurance and admissions from Coral Springs

RECO Island works with most major commercial plans held by Coral Springs employers — Florida Blue, Aetna, Cigna, UnitedHealthcare, Humana, and Blue Cross Blue Shield plans — in-network where contracted and via out-of-network benefits otherwise. Verification of benefits happens during the initial call: covered levels of care, day limits, prior authorization requirements, and an out-of-pocket estimate are documented before admission decisions are finalized. Concurrent utilization review runs through the stay to protect clinically necessary length of stay against premature step-downs.

Serving residents of: Eagle Trace, Hidden Hammocks, Parkland Isles, Cypress Run, Heron Bay.